Skriver MV, Pedersen L, Stang P, Lund L, Rothman KJ, Sorensen HT. The month of birth does not affect the risk of hypospadias. Eur J Epidemiol. 2004 Dec 1;19(12):1135-6.
Rothman KJ, Lanes S, Sacks ST. Measuring drug effects means getting a clearer signal. Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):527-8.
Rothman KJ, Mahon BE. Confounding and effect-measure modification in the evaluation of immunogenic agents. Eur J Epidemiol. 2004 Mar;19(3):205-7.
Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004 Jan 1;13(8):519-23.
Rothman KJ. A potential bias in safety evaluation during open-label extensions of randomized clinical trials. Pharmacoepidemiol Drug Saf. 2004 Jan 1;13(5):295-8.
Enger C, Nordstrom BL, Thakrar B, Sacks S, Rothman KJ. Health outcomes among patients receiving oseltamivir. Pharmacoepidemiol Drug Saf. 2004 Jan 1;13(4):227-37.
Sturmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Comparing analytic strategies using propensity and disease risk scores: the example of nonsteroidal antiinflammatory drugs (NSAID) and short-term mortality in the elderly. Am J Epidemiol. 2004 Jan 1;159(11):S67.